Literature DB >> 3371402

The cholecystokinin antagonist L-364,718 inhibits the action of cholecystokinin but not bombesin on rat pancreatic secretion in vivo.

L Anderson1, G J Dockray.   

Abstract

The action of an antagonist of peripheral CCK receptors, L-364,718 on CCK8 and bombesin-induced pancreatic exocrine secretion was studied in anaesthetized rats. Both CCK8 and bombesin increased the rate of flow and rate of enzyme secretion from the pancreas. Intravenous L-364,718 inhibited the actions of CCK8, but not those of bombesin. It is concluded that bombesin acts on the exocrine pancreas directly rather than through the release of CCK.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3371402     DOI: 10.1016/0014-2999(88)90307-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Effect of vasoactive intestinal peptide, bombesin and substance P on fluid secretion by isolated rat pancreatic ducts.

Authors:  N Ashton; B E Argent; R Green
Journal:  J Physiol       Date:  1990-08       Impact factor: 5.182

2.  Effect of endogenous cholecystokinin on the course of acute pancreatitis in rats.

Authors:  Dongmei Jia; Mitsuyoshi Yamamoto; Makoto Otsuki
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

3.  Effect of vasoactive intestinal peptide, carbachol and other agonists on the membrane voltage of pancreatic duct cells.

Authors:  C Pahl; I Novak
Journal:  Pflugers Arch       Date:  1993-08       Impact factor: 3.657

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.